Skip to main content
Sandra Zeidler and Dr. Christine Wuebben (from left to right) from Bonn at the Pitch4Med Contest at the Heinrich Heine University Düsseldorf

Honors & Funding

ImmunoSensation entrepreneurs successfully pitch an innovative approach to fight respiratory viruses with an immunostimulatory nasal spray

A team of researchers in the group of Gunther Hartmann at the Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, and the Cluster of Excellence ImmunoSensation2 successfully pitched their start-up idea of Coldex, a nasal spray that provides protection from viral infections, at the Pitch4Med Contest at the Heinrich Heine University Düsseldorf and the 2nd Medical Pitch Contest of the Medical Faculty, University of Bonn. 

At the Pitch4Med Contest in Düsseldorf in October 2023, Dr. Christine Wuebben and her co-entrepreneurs first presented their innovative idea in a ten-minute pitch in front of a top-class jury consisting of Dr. Jan Engels, Investment Manager High-Tech Gründerfonds, Rolf Fellmann, Chairman of the business angel network Angel Engine and Lars Gussen, Investment Manager TechVision Fond, who gave the young researchers valuable feedback.

The Coldex team then entered the 2nd Medical Pitch Contest during the MIB Future Panel at the Medical Faculty Bonn with a refined five-minutes pitch. The distinguished jury, consisting of Dr. Laura Pedroza (Investment Manager, Hightech Gründerfonds), Dr. Christopher Jahn (Investment Manager, TechVision Fonds), Maximilian Erb (VC Department, NRW.Bank) and Dr. Alexander Zink (Head of Technology & Innovation, Xlife Sciences) was convinced by the innovative concept and awarded Coldex the shared first place in the competition.

Thanks to its promising approach, the Coldex team recently received prototyping grants from the transfer center enacom of the University of Bonn.

Related news

Prof. Dr. Valentin Schäfer

Honors & Funding

Valentin Schäfer appointed to Specialized Ethics Committee

—Prof. Valentin S. Schäfer, Head of the Section of Rheumatology at the University Hospital Bonn (UKB) and researcher at the University of Bonn, has been appointed to the newly created Specialized Ethics Committee for Special Procedures by State Secretary Dr. Thomas Steffen at the Federal Ministry of Health. The committee, which is based at the Federal Institute for Drugs and Medical Devices (BfArM), will begin its work on July 1, 2025 and is responsible for the ethical evaluation of complex clinical trials.
View entry
Honorary Doctorate Sharon Lewin

Honors & Funding

Honorary Doctorate awarded to Sharon Lewin

—The Faculty of Medicine at the University of Bonn has conferred an honorary doctorate on the illustrious researcher Professor Sharon Lewin. The Director of the Peter Doherty Institute for Infection and Immunity and the Cumming Global Centre for Pandemic Therapeutics, Professor Lewin is also a Laureate Professor of Medicine at the University of Melbourne in Australia and collaborates with the University Hospital Bonn. She is being recognized for her exceptional research on the international stage and her groundbreaking work in the field of HIV research in particular.
View entry
Go-Bio

Honors & Funding

GO-Bio program supports innovations made in Bonn

—Five projects of ImmunoSensation2 members have received funding from the BMBF's GO-Bio initial program to put their innovative research results into practice. The projects are based at the University Hospital Bonn (UKB) and the University of Bonn and will be funded with a maximum of 100,000 euros each in the exploratory phase. The “GO-Bio initial” funding initiative of the Federal Ministry of Education and Research (BMBF) promotes the development of life science research approaches on the way to application.
View entry

Back to the news overview